Aspira Pathlab & Diagnostics share news, announcements and annual reports

BSE: 540788Healthcare ServicesSmall Cap

Aspira Pathlab & Diagnostics Limited · Face value ₹10 · Listed Dec 2017

₹127.45₹1.80 (1.43%)

Share price at the BSE close on 29 Oct 2026. Previous close ₹125.65.

29 Oct: open ₹119.40, high ₹129.00, low ₹119.40

52-week range of traded prices to 29 Oct 2026

₹49.00Low, 15 Apr 2026₹149.99High, 30 Sep 2026

Market cap: ₹131 Cr3,082nd largest listed
P/E: Lossover the last 12 months
P/B: 10.73
Dividend yield: Nonein the last 12 months
ROE: −3.7%
ROCE: −4.4%
Debt to equity: 0.11
Volume, BSE: 8,076

Aspira Pathlab & Diagnostics share news and announcements

520 announcements, routine notices left out, newest first. Page 3 of 11.

Apr 2025
- 8 Apr · Intimation Under Regulation 30 Of The SEBI (LODR) Regulations, 2015
  Announcement as per regulation 30 of the SEBI (LODR) Regulations, 2015
Mar 2025
- 25 Mar · Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations, 2015
  Enclosed herewith Form C received from Mr. Paresh Bhanushali, Promoter of the Company for the disposal of Equity Shares from the market as on March 24, 2025 and March 25, 2025 respectively.
Feb 2025
- 7 Feb · Results
  Integrated Filing (Financial) for third quarter and nine months ended December 31, 2024
- 7 Feb · Results
  Outcome of the Board Meeting dated February 07, 2025
Jan 2025
- 31 Jan · Board meeting
  Meeting on 7 Feb 2025: quarterly results
- 31 Jan · Board meeting
  Meeting of the Board of Directors of the Company is scheduled on 07/02/2025 ,inter alia, to consider and approve Unaudited Standalone ....
- 29 Jan · Reconstitution Of Audit And Stakeholder Relationship Committee W.E.F February 01, 2025
  Reconstitution of Audit and Stakeholdership Relationship Committee by appointing Mr. Manas Mengar (DIN:10218206)Independent Director of the Company as its member via Circular Resolution.
- 22 Jan · Management
  Resignation of Mr. Avinash Chander Mahajan (DIN:00041661) as Non-executive and Independent Director of the Company with the immediate effect.
- 2 Jan · Intimation For Change In The Name Of The Registrar And Share Transfer Agent
  This is to inform that the name of our Registrar and Share Transfer Agent has been changed from Link Intime India Private Limited to MUFG Intime India Private Limited
Dec 2024
- 2 Dec · Inauguration Of New Diagnostics Centre At Andheri, Mumbai
  New Diagnostics centre named as M/s. Mistry Diagnostics centre has been inaugurated w.e.f today at Andheri, Mumbai.
Nov 2024
- 12 Nov · Results
  Unaudited Standalone and Consolidated Financial Results along with Limited Review Report for quarter/half year ended September, 2024
Oct 2024
- 29 Oct · Board meeting
  Meeting on 12 Nov 2024: quarterly results
- 29 Oct · Board meeting
  Meeting of the Board of Directors of the Company is scheduled on 12/11/2024 ,inter alia, to consider and approve Unaudited Standalone ....
Sep 2024
Aug 2024
- 24 Aug · Meeting
  Book Closure & E-voting intimation dates for the purpose of 51st Annual General Meeting.
- 24 Aug · Meeting
  51st Annual General Meeting to be held on Friday, September 27, 2024 at 12.00 P.M (IST) through Video Conferencing/Other Audio Visual Means.
- 19 Aug · Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations, 2015
  Enclosed herewith Form C received from Mr. Paresh Bhanushali, Promoter of the Company for the disposal of Equity Shares from the market as on August 19, 2024.
- 13 Aug · Management
  Re-appointment of Dr. Haseeb Drabu (DIN:00489888) as the Non-Executive & Independent Director of the Company for the period of 5 years subject to the approval of the members in the ensuing ....
- 13 Aug · Board meeting
  Board of Directors in its meeting held today approved Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended June 30 ,2024
- 5 Aug · Board meeting
  Meeting on 13 Aug 2024: quarterly results
- 3 Aug · Board meeting
  Meeting of the Board of Directors of the Company is scheduled on 13/08/2024 ,inter alia, to consider and approve Unaudited Standalone ....
Jun 2024
- 29 Jun · Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations, 2015
  Enclosed herewith Form C received from Mr.Jay Bhanushali, Promoter & Director Immediate Relative of the Company for the acquisition of Equity Shares from the market as on June 28, 2024.
- 29 Jun · Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations, 2015
  Enclosed herewith Form C received from Mrs. Shraddha Bhanushali, Director & Promoters Immediate Relative of the Company for the acquisition of Equity Shares from the market as on June 28, 2024.
- 29 Jun · Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations, 2015
  Enclosed herewith Form C received from Mr. Nikunj Velji Mange, Executive Director (08489442) of the Company for the acquisition of Equity Shares from the market as on June 28, 2024.
- 8 Jun · Reminder To Update KYC Details Pursuant To SEBI Circulars
  Reminder to the Holders of the Physical Securities to furnish PAN, KYC Details and Nomination as per SEBI Circular.
May 2024
- 28 May · Management
  Appointment of Secretarial Auditor & Internal Auditor of the Company for the Financial Year 2024-2025
- 28 May · Board meeting
  Audited Financial Results for the quarter and Financial Year ended March 31, 2024
- 21 May · Board meeting
  Meeting on 28 May 2024: audited results
- 18 May · Board meeting
  Meeting of the Board of Directors of the Company is scheduled on 28/05/2024 ,inter alia, to consider and approve Audited Financial ....
Apr 2024
- 17 Apr · Compliance Certificate As Per Regulation 7(3) Of The SEBI(LODR)Regulations, 2015 For The Financial Year Ended March 31, 2024.
  Enclosed herewith Compliance Certificate pursuant to regulation 7(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the Financial Year ended March 31, 2024.
- 10 Apr · Compliance Certificate Under Regulation 40(9 & 10) Of The SEBI (LODR) Regulations, 2015 For The Year Ended March 31, 2024
  We enclose herewith certificate from Practicing Company Secretary for the period from April 01 2023 to March 31, 2024.
- 9 Apr · Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2
  Format of the Annual Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars ....
- 4 Apr · Intimation Under Regulation 30 Of The SEBI(LODR)Regulations, 2015-Incorporation Of Limited Liability Partnership.
  We wish to inform that the Company along with two other Designated Partners has incorporated Limited Liability Partnership namely "Aspira DNA Diagnostics Gujarat LLP" on April 02, 2024.
- 2 Apr · Intimation Under Regulation 30 Of SEBI(LODR)Regulation, 2015-Incorporation Of Limited Liability Partnership.
  We wish to inform that the Company along with two other Designated Partners has incorporated Limited Liability Partnership namely "Aspira DNA Diagnostics Gujarat LLP" on April 02, 2024 ....
- 1 Apr · Inauguration Of A Two New Diagnostics Centers Today In Nashik And Malad.
  Two new Diagnostics Centers namely Ashirvad Pathology Laboratory in Nashik and Shobha Diagnostics Center in Malad has been inaugurated today.
Mar 2024
- 28 Mar · Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations, 2015
  Enclosed herewith disclosure in Form C received from Mr.Jay Arvind Bhanushali, Promoters Immediate Relative of the Company for the acquisition of shares from the market.
- 22 Mar · Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations, 2015
  Enclosed herewith disclosure in Form C received from Mr. Jay Arvind Bhanushali,Promoters Immediate Relative of the Company for the acquisition of shares from the market.
- 21 Mar · Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations, 2015
  Enclosed herewith disclosure in Form C received from Mr. Nikunj Velji Mange, Executive Director (08489442) of the Company for the acquisition of shares from the market.
- 21 Mar · Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations, 2015
  Enclosed herewith disclosure in Form C received from Mrs. Shraddha Bhanushali, Director Immediate Relative of the Company for the acquisition of shares from the market.
- 20 Mar · Reconstitution Of Stakeholder Relationship Committee
  Reconstitution of Stakeholder Relationship Committee by appointing Mr. Pankaj Shah (DIN:02836324), Managing Director & CEO of the Company w.e.f 20th March, 2024 as the member of this committee ....
- 19 Mar · Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations, 2015
  Enclosed herewith disclosure in Form C received from Mrs. Shraddha Bhanushali ,Directors Immediate Relative of the Company for the acquisition of shares from the market.
- 15 Mar · Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations, 2015
  Enclosed herewith disclosure in Form C received from Mr.Jay Arvind Bhanushali,Promoters Immediate Relative of the Company for the acquisition of shares from the market.
- 13 Mar · Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations, 2015
  Please find attached disclosure in Form C from Mr. Jay Arvind Bhanushali, Promoters Immediate Relative of the Company for the acquisition of shares from the market.
- 13 Mar · Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations, 2015
  Please find attached disclosure in Form C received from Mr. Nikunj Velji Mange, Executive Director (08489442) of the Company for the acquisition of shares from the market.
- 6 Mar · Reconstitution Of Audit Committee Of The Company
  Reconstitution of Audit Committee by appointing Mr. Nikunj Mange, Executive Director (DIN:08489442) of the Company w.e.f 06th March, 2024 as the member of this committee by way of the circular ....
- 2 Mar · Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations, 2015
  Please find attached disclosure in Form C received from Mr. Nikunj Velji Mange, Executive Director (DIN:08489442) of the Company for the acquisition of shares from the market.

Aspira Pathlab & Diagnostics share news and announcements

Apr 2025

Mar 2025

Feb 2025

Jan 2025

Dec 2024

Nov 2024

Oct 2024

Sep 2024

Aug 2024

Jun 2024

May 2024

Apr 2024

Mar 2024